The use of Orajel, a topical anesthetic commonly used for teething, is generally not advised for children under the age of two due to the potential risk of methemoglobinemia, a life-threatening condition that reduces the ability of the blood to carry oxygen. This risk is particularly high with over-the-counter Orajel gels and solutions that contain benzocaine, a local anesthetic.
When Orajel is applied topically to the gums, it can provide temporary relief from pain or discomfort associated with teething.However, the high likelihood of methemoglobinemia in young children, combined with the product's packaging featuring cute animals or imagery that might lead consumers to believe it is safe for children, highlight the need for caution.
For children who are two years old or older, where the potential benefits of teething on the gum may outweigh the risks of methemoglobinemia, it is generally recommended to use Orajel as directed by a healthcare professional, following the manufacturer's instructions carefully.
Children with a history of methemoglobinemia in the past, other genetic or inherited enzyme deficiencies, respiratory conditions, smoking, or pregnant or breastfeeding women should avoid using Orajel entirely., while Orajel may be safe and effective for some children over two years of age, its use in children under two should be avoided due to the known risk of methemoglobinemia. Always consult with a healthcare provider before using this or any other medication intended for teething or口腔问题.
